New antibody drug tested to control serious kidney disease
Disease control
Completed
This study tested a new antibody drug called MIL62 for treating primary membranous nephropathy, a serious autoimmune kidney disease. It compared two doses of MIL62 against an older drug, cyclosporine, in 94 adults. The main goals were to see if MIL62 was safe and if it could help…
Phase: PHASE1, PHASE2 • Sponsor: Beijing Mabworks Biotech Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC